All Circulars (28174)
Browse all regulatory circulars from India’s major stock exchanges and market regulator. Navigate by source using the buttons below or explore individual circulars in the grid.
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE admits Finverse Platform Private Limited and Religo Broking Private Limited as new trading members with Cash and Equity Derivatives … | |||||||||||||||
BSE admits Finverse Platform Private Limited and Religo Broking Private Limited as new trading members with Cash and Equity Derivatives segments.
| |||||||||||||||
BSE admits Finverse Platform Private Limited and Religo Broking Private Limited as new trading members with cash and equity derivatives … | |||||||||||||||
BSE admits Finverse Platform Private Limited and Religo Broking Private Limited as new trading members with cash and equity derivatives segments rights.
| |||||||||||||||
BSE admits Finverse Platform Private Limited and Religo Broking Private Limited as new deposit-based trading members with Cash and Equity … | |||||||||||||||
BSE admits Finverse Platform Private Limited and Religo Broking Private Limited as new deposit-based trading members with Cash and Equity Derivatives trading rights.
| |||||||||||||||
MEDINOVA DIAGNOSTIC SERVICES LTD to merge into VIJAYA DIAGNOSTIC CENTRE LTD with shareholders receiving 1 equity share for every 22 shares … | |||||||||||||||
MEDINOVA DIAGNOSTIC SERVICES LTD to merge into VIJAYA DIAGNOSTIC CENTRE LTD with shareholders receiving 1 equity share for every 22 shares held. Trading in MEDINOVA shares suspended from November 25, 2025.
| |||||||||||||||
NCLT approved scheme of amalgamation for merger of MEDINOVA DIAGNOSTIC SERVICES LTD into VIJAYA DIAGNOSTIC CENTRE LTD with record date … | |||||||||||||||
NCLT approved scheme of amalgamation for merger of MEDINOVA DIAGNOSTIC SERVICES LTD into VIJAYA DIAGNOSTIC CENTRE LTD with record date November 25, 2025.
| |||||||||||||||
NSE announces securities shortlisted under Long-Term ASM Framework Stage I and IV, effective November 19, 2025, with two securities added to … | |||||||||||||||
NSE announces securities shortlisted under Long-Term ASM Framework Stage I and IV, effective November 19, 2025, with two securities added to Stage I surveillance.
| |||||||||||||||
NSE updates Enhanced Surveillance Measure framework with new securities added to ESM Stage-I, including Mega Flex Plastics Limited and … | |||||||||||||||
NSE updates Enhanced Surveillance Measure framework with new securities added to ESM Stage-I, including Mega Flex Plastics Limited and Nephro Care India Limited moving to Stage-II.
| |||||||||||||||
BSE circular regarding securities being added to, moved within, or removed from the Long Term Additional Surveillance Measure (LT-ASM) … | |||||||||||||||
BSE circular regarding securities being added to, moved within, or removed from the Long Term Additional Surveillance Measure (LT-ASM) framework effective November 19, 2025.
| |||||||||||||||
BSE announces changes to Long Term ASM Framework effective November 19, 2025, including new securities shortlisted, movements between ASM … | |||||||||||||||
BSE announces changes to Long Term ASM Framework effective November 19, 2025, including new securities shortlisted, movements between ASM stages, and securities moving out of the framework.
| |||||||||||||||
BSE circular regarding securities entering, exiting, and moving between stages in the Long Term Additional Surveillance Measure framework … | |||||||||||||||
BSE circular regarding securities entering, exiting, and moving between stages in the Long Term Additional Surveillance Measure framework effective November 19, 2025.
| |||||||||||||||